Cell-cell interactions in the heart: advanced cardiac models and omics technologies
S Tan, J Yang, S Hu, W Lei - Stem Cell Research & Therapy, 2024 - Springer
A healthy heart comprises various cell types, including cardiomyocytes, endothelial cells,
fibroblasts, immune cells, and among others, which work together to maintain optimal …
fibroblasts, immune cells, and among others, which work together to maintain optimal …
Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments
In the modern world, myocardial infarction is one of the most common cardiovascular
diseases, which are responsible for around 18 million deaths every year or almost 32% of all …
diseases, which are responsible for around 18 million deaths every year or almost 32% of all …
[HTML][HTML] Central role of the p53 pathway in the noncoding-RNA response to oxidative stress
P Fuschi, M Carrara, C Voellenkle… - Aging (Albany …, 2017 - ncbi.nlm.nih.gov
Oxidative stress plays a fundamental role in many conditions. Specifically, redox imbalance
inhibits endothelial cell (EC) growth, inducing cell death and senescence. We used global …
inhibits endothelial cell (EC) growth, inducing cell death and senescence. We used global …
[HTML][HTML] Engineered circulatory scaffolds for building cardiac tissue
S Huang, Y Yang, Q Yang, Q Zhao… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Heart failure (HF) is the terminal state of cardiovascular disease (CVD), leading numerous
patients to death every year. Cardiac tissue engineering is a multidisciplinary field of …
patients to death every year. Cardiac tissue engineering is a multidisciplinary field of …
CRISPR/Cas9 edited induced pluripotent stem cell-based vascular tissues to model aging and disease-dependent impairment
A Acun, P Zorlutuna - Tissue Engineering Part A, 2019 - liebertpub.com
The discovery of induced pluripotent stem cells (iPSCs) and advancements in genome
editing technology introduced a new perspective to disease modeling as genetic factors can …
editing technology introduced a new perspective to disease modeling as genetic factors can …
Revealing the pathogenic changes of PAH based on multiomics characteristics
L Zhang, S Chen, X Zeng, D Lin, Y Li, L Gui… - Journal of Translational …, 2019 - Springer
Background Pulmonary artery hypertension (PAH), which is characterized by an increase in
pulmonary circulation blood pressure, is a fatal disease, and its pathogenesis remains …
pulmonary circulation blood pressure, is a fatal disease, and its pathogenesis remains …
Advances in the design, generation, and application of tissue-engineered myocardial equivalents
G Bernava, L Iop - Frontiers in Bioengineering and Biotechnology, 2023 - frontiersin.org
Due to the limited regenerative ability of cardiomyocytes, the disabling irreversible condition
of myocardial failure can only be treated with conservative and temporary therapeutic …
of myocardial failure can only be treated with conservative and temporary therapeutic …
3D bioprinted aged human post‐infarct myocardium tissue model
Abstract Background and Aims Fibrotic tissue formed after myocardial infarction (MI) can be
as detrimental as MI itself. However, current in vitro cardiac fibrosis models fail to …
as detrimental as MI itself. However, current in vitro cardiac fibrosis models fail to …
GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans
Inborn errors of immunity (IEIs) unveil regulatory pathways of human immunity. We describe
a new IEI caused by mutations in the GTPase of the immune-associated protein 6 (GIMAP6) …
a new IEI caused by mutations in the GTPase of the immune-associated protein 6 (GIMAP6) …
[HTML][HTML] 类器官和立体细胞模型在中药心脏毒性评价中的应用前景
刘昕彦, 邵瑞, 贺爽, 朱彦 - 药学学报, 2019 - html.rhhz.net
心脏毒性是导致药物研发失败和上市后撤市的原因之一. 然而, 目前的药物心脏毒性评价方法
存在临床相关性低, 重现性低, 处理量小等缺点. 建立准确可靠的方法评价药物的心脏毒性是当前 …
存在临床相关性低, 重现性低, 处理量小等缺点. 建立准确可靠的方法评价药物的心脏毒性是当前 …